SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               ------------------

                                    FORM 8-K

              CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)   April 18, 2003


                           UNIGENE LABORATORIES, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

          DELAWARE                   0-16005                    22-2328609
(STATE OR OTHER JURISDICTION       (COMMISSION              (I.R.S. EMPLOYER
      OF INCORPORATION)            FILE NUMBER)            IDENTIFICATION NO.)

                              110 LITTLE FALLS ROAD
                          FAIRFIELD, NEW JERSEY 07004
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE         (973) 882-0860




Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits

     (c)  Exhibits.

          99.1  Certification by Warren P. Levy, Chief Executive Officer,
                pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
                Section 906 of the Sarbanes-Oxley Act of 2002

          99.2  Certification by Jay Levy, Chief Financial Officer, pursuant to
                18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
                the Sarbanes-Oxley Act of 2002

Item 9.  Regulation FD Disclosure

On April 18, 2003, Warren P. Levy, Chief Executive Officer, and Jay Levy, Chief
Financial Officer, of Unigene Laboratories, Inc. each delivered to the
Securities and Exchange Commission ("SEC") a sworn statement pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.

Copies of the sworn statements and certifications of Messrs. Levy and Levy are
filed herewith as Exhibits 99.1 and 99.2, respectively.

Limitation of Incorporation by Reference

In accordance with general instruction B.2 of form 8-K, the information in this
report is furnished pursuant to Item 9 and shall not be deemed to be "filed" for
the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise
subject to the liability of that section.



SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        UNIGENE LABORATORIES, INC.

                                        /s/ Warren P. Levy
                                        --------------------------
Date:  April 18, 2003                   By: Warren P. Levy
                                        President
                                        (Chief Executive Officer)



Section 1.        EXHIBIT INDEX

Exhibit Number    Description

99.1              Certification by Warren P. Levy, Chief Executive Officer,
                  pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002

99.2              Certification by Jay Levy, Chief Financial Officer, pursuant
                  to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
                  of the Sarbanes-Oxley Act of 2002